Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Early Phase 1First-in-human
1(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (100.0%)

Trials by Status

recruiting133%
completed267%

Recent Activity

1 active trials
Showing 3 of 3
completed

An Exosomal miRNA-based Liquid Biopsy for ICC Detection

NCT07225452
recruiting

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

NCT07226154
completedearly_phase_1

Time Course of Endometrium's Gene Expression Profiles Using Endometrial Tissue and Blood Samples

NCT06786273

Clinical Trials (3)

Showing 3 of 3 trials
NCT07225452

An Exosomal miRNA-based Liquid Biopsy for ICC Detection

Completed
NCT07226154

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

Recruiting
NCT06786273Early Phase 1

Time Course of Endometrium's Gene Expression Profiles Using Endometrial Tissue and Blood Samples

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3